Industry
Biotechnology
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.
Loading...
Open
12.94
Mkt cap
103M
Volume
60K
High
13.30
P/E Ratio
5.42
52-wk high
26.38
Low
12.43
Div yield
N/A
52-wk low
5.85
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.